Filing Details

Accession Number:
0001181431-10-035071
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-06-29 13:00:00
Reporting Period:
2010-06-25
Filing Date:
2010-06-29
Accepted Time:
2010-06-29 18:23:29
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1086467 Drugstore Com Inc DSCM Retail-Drug Stores And Proprietary Stores (5912) 043416255
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1365416 Eugene Ronald Kelly 411 108Th Ave Se
Suite 1400
Bellevue WA 98004
Vp, Customer & Pharmacy Ops No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-06-25 5,143 $1.93 117,281 No 4 M Direct
Common Stock Disposition 2010-06-25 5,143 $3.40 112,138 No 4 S Direct
Common Stock Disposition 2010-06-25 10,000 $3.40 102,138 No 4 S Direct
Common Stock Disposition 2010-06-25 14,963 $3.50 87,175 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2010-06-25 5,143 $3.40 5,143 $1.93
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2001-12-31 2012-02-08 No 4 M Direct
Footnotes
  1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 05/25/2010.
  2. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 05/25/2010.
  3. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 05/25/2010.
  4. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 05/25/2010.
  5. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 05/25/2010.
  6. Indicates vesting commencement date; the stock option becomes exercisable as to the option's original share total over 48 months, at the rate of 20% six months from the vesting commencement date and the remaining 80% vesting in equal increments at the end of each quarterly period thereafter.